Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs AgelessRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AgelessRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 24 · Grade B

AgelessRx

Visit AgelessRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 85 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make AgelessRx a bad call — it's best for readers comparing brand access and monitoring with lower-dose compounded programs who want the care fee separated from medication costs. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
84
Supply Reliability
95
85
Transparency
90
82
Access Breadth
93
84
Clinical Oversight
92
84
Track Record
88
88
CoreAge RxBrief Score 94 · 85AgelessRx

Price, coverage & the tracker

CoreAge RxAgelessRx
Brief Score94/100 (A)85/100 (B)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Low-dose compound from $99/mo

Standard-dose compounded quote is not established.

Brand Wegovy pill: $349/mo ongoing combined cost; introductory totals $199 then $249.

Full price details

Standard-dose compounded quote unknown; low-dose compound from $99/month. Wegovy pill $349/month ongoing combined cost; introductory totals $199 then $249

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Low-dose offer: $109 first month

Compounded renewal price is not established.

Brand Zepbound from $364/mo: $65 care plus medication from $299; dose/refill conditions apply.

Full price details

Low-dose compounded renewal unknown; $109 first month. Zepbound from $364/month ($65 care plus medication from $299); dose/refill conditions apply

CoverageUS only; restrictions by state, confirmed at intakeProgram-specific state availability requires confirmation
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

AgelessRx: Brand access involves a recurring care fee plus a separate prescription payment. Lower-dose compounded prices describe different programs, not discounted brand treatment.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.